Effectiveness of Cilostazol on cerebral vasospasm after subarachnoid hemorrhage
Not Applicable
- Conditions
- subarachnoid hemorrhage
- Registration Number
- JPRN-UMIN000004347
- Lead Sponsor
- niversity of Yamanashi, Faculty of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with congestive heart failure, cilostazol hypersensitivity, pregnancy. 2. Patients with Hemophilia, gastrointestinal bleeding, history of intracerebral hemorrhage. 3. Patients with malignant tumor, liver failure, and renal failure. 4. patients judged improper candidate by doctor.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequency of delayed ischemic neurological deficits
- Secondary Outcome Measures
Name Time Method 1.Angiographical vasospasm on digital subtraction angiography or computed tomographic angiography 2.infarction caused by vasospasm 3.outcome (modified rankin scale) 4.length of hospitalization